Anthropic Enters Drug Discovery, Oura Tracks Psychedelics, Life Time Bets on GLP-1s

July 1, 2026: Your daily rundown of health and wellness news, in under 5 minutes.

Today's top stories:

• Life Time CEO Bahram Akradi calls GLP-1 threat "a wrong bet," positioning MIORA clinics as companion to treatment as research shows pairing exercise could prevent 50,000 cardiovascular events
• Oura joins research initiative providing biometric data to study veterans undergoing psychedelic therapies, adding continuous physiological context to mental healthcare
• Anthropic launches Claude Science and internal drug discovery program focused on neglected diseases, using AI directly rather than just selling tools to life sciences companies

More from Fitt:

Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital.

Subscribe to our newsletter → insider.fitt.co/subscribe 

Work with our recruiting firm → https://talent.fitt.co/

Follow us on Instagram → https://www.instagram.com/fittinsider/

Follow us on LinkedIn → linkedin.com/company/fittinsider 

Reach out → [email protected]